DTU Logo
Publications | Conference abstracts | Slidesets | Webcasts

Publications (14 of 403)


Search Publications :

2014

Chronic Obstructive Pulmonary Disease and Cardiovascular Risk: Insights from the NAVIGATOR Trial
Pedro G.M. de Barros e Silva, Robert M. Califf, Jie-Lena Sun, John J.V. McMurray, Rury R. Holman, Steven Haffner, Laine Thomas, Renato D. Lopes
International Joural of Cardiology 2014;176:1126-1128, Published:25-Mar-2015, Epub:12-Aug-2014, PMID:25220176, doi:10.1016/j.ijcard.2014.07.297

Performance of the UKPDS Outcomes Model for Prediction of Myocardial Infarction and Stroke in the ADDITION-Europe Trial Cohort: does the ADDITION validation add up?
Alastair Gray, Rury Holman, Philip Clarke, Jose Leal
Value in Health 2014;17:895-6, Published:Dec-2014, Epub:22-Sep-2014, PMID:25498785, doi:10.1016/j.jval.2014.07.008

Change in levels of physical activity after diagnosis of type 2 diabetes: an observational analysis from the NAVIGATOR study
D. Preiss, S. M. Haffner, L. E.Thomas, J.-L. Sun, N. Sattar, T. Yates, M. J Davies, J. J. McMurray, R. R. Holman, R. M. Califf & W. E. Kraus
Diabetes Obesity and Metabolism 2014;16:1265-1268, Published:Dec-2014, Epub:19-Jun-2014, PMID:24861892, doi:10.1111/dom.12320

Heart failure: a cardiovascular outcome in diabetes that can no longer be ignored
Prof John J V McMurray MD, Prof Hertzel C Gerstein MD, Prof Rury R Holman FRCP, Prof Marc A Pfeffer MD
Lancet Diabetes Endocrinol. 2014;2:843-851, Published:Oct-2014, Epub:13-Mar-2014, PMID:24731668, doi:10.1016/S2213-8587(14)70031-2

Cardiovascular outcome trials of glucose-lowering strategies in type 2 diabetes. Authors' reply
Rury R. Holman, Harald Sourij, Robert M. Califf
The Lancet 2014;384:1097-1098, Published:20-Sep-2014, PMID:25241719, doi:10.1016/S0140-6736(14)61674-3

Blood pressure-lowering treatment based on cardiovascular risk: a meta-analysis of individual patient data
The Blood Pressure Lowering Treatment Trialists' Collaboration
The Lancet 2014;384:591-598, Published:16-Aug-2014, Epub:14-Aug-2014, PMID:25131978, doi:10.1016/S0140-6736(14)61212-5

Cardiovascular endocrinology: First-time heart failure increases risk of diabetes mellitus
Rury R. Holman
Nat. Rev. Endocrinol. 2014;10:453-454, Published:Aug-2014, Epub:01-Jul-2014, PMID:24981458, doi:10.1038/nrendo.2014.105

Rationale for and design of the Acarbose Cardiovascular Evaluation (ACE) trial
Rury R Holman, Mary A Bethel, Juliana CN Chan, Jean-Louis Chiasson, Zoë Doran, Junbo Ge, Hertzel Gerstein, Yong Huo, John J McMurray, Lars Ryden, Winitha Liyanage, Stefan Schröder, Michal Tendera, Michael J Theodorakis, Jaakko Tuomilehto, Wenying Yang, Dayi Hu, Changyu Pan for the ACE Study Group
American Heart Journal 2014;168:23-29, Published:Jul-2014, Epub:05-Apr-2014, PMID:24952856, doi:10.1016/j.ahj.2014.03.021

Cardiovascular outcome trials of glucose-lowering drugs or strategies in type 2 diabetes
Rury R Holman, Harald Sourij, Robert M Califf
Lancet 2014;383:2008-17, Published:07-Jun-2014, Epub:05-Jun-2014, PMID:24910232, doi:10.1016/S0140-6736(14)60794-7

On the potential of acarbose to reduce cardiovascular disease
Eberhard Standl, Michael J Theodorakis, Michael Erbach, Oliver Schnell and Jaakko Tuomilehto
Cardiovascular Diabetology 2014;13:81, Published:16-Apr-2014, PMID:24742256, doi:10.1186/1475-2840-13-81

Impact of baseline physical activity and diet behavior on metabolic syndrome in a pharmaceutical trial: Results from NAVIGATOR
Huffman KM, Sun JL, Thomas L, Bales CW, Califf RM, Yates T, Davies MJ, Holman RR, McMurray JJ, Bethel MA, Tuomilehto J, Haffner SM, Kraus WE.
Metabolism 2014;63:554-561, Published:Apr-2014, Epub:15-Jan-2014, PMID:24559843, doi:10.1016/j.metabol.2014.01.002

Association between change in daily ambulatory activity and cardiovascular events in people with impaired glucose tolerance (NAVIGATOR trial): a cohort analysis
Thomas Yates, Steven M Haff ner, Phillip J Schulte, Laine Thomas, Kim M Huff man, Connie W Bales, Robert M Califf , Rury R Holman, John J V McMurray, M Angelyn Bethel, Jaakko Tuomilehto, Melanie J Davies, William E Kraus
Lancet 2014;383:1059-66, Published:22-Mar-2014, Epub:20-Dec-2013, PMID:24361242, doi:10.1016/S0140-6736(13)62061-9

Ethnicity and long-term vascular outcomes in Type 2 diabetes: a prospective observational study (UKPDS 83)
T. M. E. Davis, R. L. Coleman and R. R. Holman for the UKPDS Group
Diabetic Medicine 2014;31:200-207, Published:Feb-2014, Epub:22-Nov-2013, PMID:24267048, doi:10.1111/dme.12353

Metformin for non-diabetic patients with coronary heart disease (the CAMERA study): a randomised controlled trial
David Preiss, Suzanne M Lloyd, Ian Ford, John J McMurray, Rury R Holman, Paul Welsh, Miles Fisher, Chris J Packard, Naveed Sattar
Lancet Diabetes & Endocrinology 2014;2:116-124, Published:Feb-2014, Epub:07-Nov-2013, PMID:24622715, doi:10.1016/S2213-8587(13)70152-9